Estrogenic activity, race/ethnicity, and Indigenous American ancestry among San Francisco Bay Area women
- PMID: 30908519
- PMCID: PMC6433244
- DOI: 10.1371/journal.pone.0213809
Estrogenic activity, race/ethnicity, and Indigenous American ancestry among San Francisco Bay Area women
Abstract
Estrogens play a significant role in breast cancer development and are not only produced endogenously, but are also mimicked by estrogen-like compounds from environmental exposures. We evaluated associations between estrogenic (E) activity, demographic factors and breast cancer risk factors in Non-Latina Black (NLB), Non-Latina White (NLW), and Latina women. We examined the association between E activity and Indigenous American (IA) ancestry in Latina women. Total E activity was measured with a bioassay in plasma samples of 503 women who served as controls in the San Francisco Bay Area Breast Cancer Study. In the univariate model that included all women with race/ethnicity as the independent predictor, Latinas had 13% lower E activity (p = 0.239) and NLBs had 35% higher activity (p = 0.04) compared to NLWs. In the multivariable model that adjusted for demographic factors, Latinas continued to show lower E activity levels (26%, p = 0.026), but the difference between NLBs and NLWs was no longer statistically significant (p = 0.431). An inverse association was observed between E activity and IA ancestry among Latina women (50% lower in 0% vs. 100% European ancestry, p = 0.027) consistent with our previously reported association between IA ancestry and breast cancer risk. These findings suggest that endogenous estrogens and exogenous estrogen-like compounds that act on the estrogen receptor and modulate E activity may partially explain racial/ethnic differences in breast cancer risk.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Williams G. P., “The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease,” Eur. J. Cancer Prev., vol. 19, no. 4, pp. 256–271, July 2010. - PubMed
-
- Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam A. W., Allen N. E., l P., and Key T. J., “Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies,” J. Natl. Cancer Inst., vol. 100, no. 3, pp. 170–183, February 2008. 10.1093/jnci/djm323 - DOI - PMC - PubMed
-
- “Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies,” J Natl Cancer Inst, vol. 94, no. 8, pp. 606–616, April 2002. - PubMed
-
- Setiawan V. W., Haiman C. A., Stanczyk F. Z., Le Marchand L., and Henderson B. E., “Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study,” Cancer Epidemiol. Biomarkers Prev., vol. 15, no. 10, pp. 1849–1855, October 2006. 10.1158/1055-9965.EPI-06-0307 - DOI - PubMed
